About MicuRx
Scientific research
Pipeline
Newsroom
- Corporate news
Careers
Contact Us

Contezolid: First Approval

Time:2021-11-01 / View:11 times

Prev: A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro

Next:

Back

Copyright © 2021 All Rights Reserved MicuRx Pharmaceuticals, Inc.

Medical Representative Recordation Platform 沪ICP备12020812号